Green Alpha Advisors, LLC Athersys, Inc Transaction History

Green Alpha Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	BUY	$0.18 - $0.86 $92,337 - $441,166	512,984 Added 232.64%	733,487 $191,000
Q1 2022 Apr 19, 2022	BUY	$0.6 - $1.06 $13,878 - $24,518	23,131 Added 11.72%	220,503 $134,000
Q4 2021 Jan 12, 2022	BUY	$0.85 - $1.4 $5,210 - $8,582	6,130 Added 3.21%	197,372 $178,000
Q3 2021 Oct 12, 2021	BUY	$1.33 - $1.77 $17,867 - $23,778	13,434 Added 7.56%	191,242 $254,000
Q2 2021 Jul 22, 2021	BUY	$1.41 - $1.94 $250,709 - $344,947	177,808 New	177,808 $256,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Green Alpha Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Green Alpha Advisors, LLC with notifications on news.